Gastroesophageal reflux disease Trials in Salt Lake City, United States
Conditions / Gastroesophageal reflux disease / Salt Lake City, United States
Gastroesophageal reflux disease is a medical condition with active clinical research programs worldwide.
10 total trials for this combination
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00255190 | Safety and Quality of Life Study of Dexlansoprazole Modified Release Formulation to Treat Heartburn | COMPLETED | PHASE3 |
| NCT00321984 | Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Gastroesophageal Reflux Disease | COMPLETED | PHASE3 |
| NCT02186652 | PK Study With Pantoprazole in Obese Children and Adolescents | COMPLETED | PHASE1 |
| NCT01642602 | Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules in Treating Symptomatic Non-Erosive Gastroesophageal Reflux Disease in Adolescents | COMPLETED | PHASE2 |
| NCT00132496 | Treatment of Gastroesophageal Reflux Disease in 12-16 Year Old Patients With Rabeprazole | COMPLETED | PHASE2 |
| NCT01642615 | Safety and Efficacy of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis and Maintenance of Healed Erosive Esophagitis and Relief of Heartburn in Adolescents | COMPLETED | PHASE2 |
| NCT00251745 | Efficacy and Safety of Dexlansoprazole Modified Release Formulation to Treat Heartburn | COMPLETED | PHASE3 |
| NCT00251758 | Safety and Efficacy of Dexlansoprazole Modified Release Formulation to Treat Heartburn | COMPLETED | PHASE3 |
| NCT00978016 | A Study to Evaluate the Efficacy and Safety of Arbaclofen Placarbil (XP19986) as Adjunctive Therapy in Subjects With Gastroesophageal Reflux Disease (GERD) | COMPLETED | PHASE2 |
| NCT02401035 | PREA, PK And Safety PASS Study Of IV Pantoprazole In Pediatric Subjects | TERMINATED | PHASE4 |